For answers to the above questions, it is imperative to elucidate the critical molecular switch that controls the role reversal of FOSB, and the exact molecular mechanisms by which FOSB has radically opposite impacts on the progression and prognosis of lung cancer within defined contexts. The gene discussed is FOSB; the disease is lung carcinoma.